Recent Articles

All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.

Infographic showing Cagrilintide’s multi-pathway stroke defense through metabolic, vascular, and neuroprotection.

Does Scientific Research Support Cagrilintide’s...

Explore how Cagrilintide supports stroke prevention and cardiovascular research through metabolic regulation and vascular protection. Learn about its mechanisms, ongoing clinical trials, and comparison with other antidiabetic agents. Discover how Peptidic’s high-purity research peptides empower scientists with consistent, reliable results for metabolic and cerebrovascular studies, advancing global innovation in peptide-based cardiovascular and stroke research.

 

 

Posted in: News

read more
Diagram showing GLP-1 receptor pathways regulating lipid metabolism, oxidation, and cholesterol efflux.

Can GLP-1 Pathways Help Regulate Lipid Metaboli...

This blog explains how GLP-1 pathways play a crucial role in regulating lipid metabolism and maintaining vascular health. It examines their impact on fatty acid oxidation, triglyceride synthesis, and cholesterol efflux. The discussion highlights how GLP-1 signaling combats atherogenic dyslipidemia. Together, these insights reveal their importance in improving lipid balance and cardiovascular outcomes.

Posted in: News

read more
Infographic image showing how AOD 9604 enhances diabetic wound healing through cellular repair.

Can AOD Accelerate Healing in Diabetic Foot Ulc...

Discover how AOD 9604, a synthetic peptide fragment of human growth hormone, is being studied for its potential role in diabetic wound research. Scientific investigations have explored its effects on collagen synthesis, cellular signaling, and tissue regeneration under controlled laboratory conditions. At Peptidic, we focus on advancing peptide science by providing research-grade AOD9604 for experimental use, supporting ongoing studies that aim to deepen the understanding of peptide-based mechanisms in diabetic wound healing.

 

 

Posted in: News

read more
Diagram image showing Cagrilintide’s benefits for kidney, metabolic, and cardiovascular health in CKD.

Is Cagrilintide Safe for Chronic Kidney Disease...

Discover how Cagrilintide supports safe and effective weight management in chronic kidney disease (CKD) patients. Learn about its role in improving metabolic health, kidney protection, and cardiovascular stability. Explore clinical studies, therapeutic benefits, and Peptidic’s high-quality research peptides designed to advance CKD and obesity research with precision, purity, and scientific excellence.

 

Posted in: News

read more
Diagram showing sermorelin’s neuroprotective cycle, illustrating GH/IGF-1 release, reduced stress, and enhanced neurogenesis.

The Role of Sermorelin in Supporting Cognitive ...

Discover how Sermorelin supports brain health and combats age-related cognitive decline by naturally boosting growth hormone (GH) and IGF-1 levels. Learn its scientifically proven benefits, neuroprotective mechanisms, and how Peptidic’s pharmaceutical-grade Sermorelin therapy promotes mental clarity, focus, and long-term neurological vitality for healthy aging. Explore research-backed solutions for enhanced cognitive performance and brain wellness.

Posted in: News

read more
Image showing Retatrutide’s triple agonist mechanism activating GIP, GLP-1, and Glucagon receptors for metabolic improvement.

Where Does Retatrutide Stand in the Advancement...

Retatrutide represents a groundbreaking advancement in peptide therapeutics, offering a powerful triple-agonist mechanism that targets GLP-1, GIP, and glucagon receptors. Backed by Peptidic’s research-grade innovation, it delivers exceptional results in metabolic regulation, weight management, and energy balance, paving the way for next-generation solutions in the treatment of obesity, diabetes, and cardiovascular risk reduction.

 

Posted in: News

read more